Skip to content

Insider · CIK 0002001873

Menelas N Pangalos

director

Files at BIIB (BIOGEN INC.), ABSI (Absci Corp). First filing Sep 24, 2025, latest Sep 24, 2025.

Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
1 / 0
$255k bought, $0 sold

Where the trades landed

Last year at the company this insider has traded most, with each buy and sell on the bar it happened.

ABSI: Absci Corp

ABSIOct 9, 2026 · close 10.16

Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™

Signals

This insider’s open-market buys and sells, scored.

ScoreCompanyValueHoldingsPrice contextFiled
46Moderate
ABSIbuy 2
Absci Corp
$255k
95,785 shares
+527%-

Transactions

Every row this insider has filed, newest first.

DateCompanyTransactionSharesPriceValueHoldings afterFiled
Sep 22, 2025ABSI
Absci Corp
POpen-market purchase
Common Stock
+95,785$2.66$255k113,960Sep 24, 2025
Jun 17, 2025BIIB
BIOGEN INC.
AGrant or award
Restricted Stock Unitderivative
+2,370$0.00$02,370Jun 18, 2025
Jun 11, 2025ABSI
Absci Corp
AGrant or award
Common Stock
+14,500$0.00$018,175Jun 12, 2025
Jun 11, 2025ABSI
Absci Corp
AGrant or award
Stock Option (right to buy)derivative
+57,400$0.00$057,400Jun 12, 2025

Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.

Menelas N Pangalos: insider trades and track record | InsiderTell